nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00737	0.00737	CbGpPWpGaD
Dexamethasone—CYP3A43—Biological oxidations—MAOA—conduct disorder	0.00735	0.00735	CbGpPWpGaD
Dexamethasone—CYP3A43—Metapathway biotransformation—COMT—conduct disorder	0.0073	0.0073	CbGpPWpGaD
Dexamethasone—NOS2—ATF-2 transcription factor network—EP300—conduct disorder	0.0073	0.0073	CbGpPWpGaD
Dexamethasone—ANXA1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00726	0.00726	CbGpPWpGaD
Dexamethasone—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.00688	0.00688	CbGpPWpGaD
Dexamethasone—NOS2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00667	0.00667	CbGpPWpGaD
Dexamethasone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00649	0.00649	CbGpPWpGaD
Dexamethasone—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00642	0.00642	CbGpPWpGaD
Dexamethasone—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00633	0.00633	CbGpPWpGaD
Dexamethasone—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00618	0.00618	CbGpPWpGaD
Dexamethasone—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0061	0.0061	CbGpPWpGaD
Dexamethasone—CYP17A1—Biological oxidations—COMT—conduct disorder	0.00567	0.00567	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CGA—conduct disorder	0.00566	0.00566	CbGpPWpGaD
Dexamethasone—CYP17A1—Biological oxidations—MAOA—conduct disorder	0.00563	0.00563	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—DRD4—conduct disorder	0.00561	0.00561	CbGpPWpGaD
Dexamethasone—CYP17A1—Metapathway biotransformation—COMT—conduct disorder	0.00559	0.00559	CbGpPWpGaD
Dexamethasone—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00558	0.00558	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—POLR3A—conduct disorder	0.00523	0.00523	CbGpPWpGaD
Dexamethasone—ABCC2—NRF2 pathway—SLC6A4—conduct disorder	0.00521	0.00521	CbGpPWpGaD
Dexamethasone—CYP11A1—Biological oxidations—COMT—conduct disorder	0.00519	0.00519	CbGpPWpGaD
Dexamethasone—CYP11A1—Biological oxidations—MAOA—conduct disorder	0.00515	0.00515	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CGA—conduct disorder	0.00514	0.00514	CbGpPWpGaD
Dexamethasone—CYP4A11—Biological oxidations—COMT—conduct disorder	0.00513	0.00513	CbGpPWpGaD
Dexamethasone—CYP11A1—Metapathway biotransformation—COMT—conduct disorder	0.00511	0.00511	CbGpPWpGaD
Dexamethasone—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00511	0.00511	CbGpPWpGaD
Dexamethasone—CYP4A11—Biological oxidations—MAOA—conduct disorder	0.0051	0.0051	CbGpPWpGaD
Dexamethasone—PGR—Validated nuclear estrogen receptor alpha network—EP300—conduct disorder	0.00496	0.00496	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00482	0.00482	CbGpPWpGaD
Dexamethasone—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00481	0.00481	CbGpPWpGaD
Dexamethasone—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00472	0.00472	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00456	0.00456	CbGpPWpGaD
Dexamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—conduct disorder	0.00444	0.00444	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00441	0.00441	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00437	0.00437	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00432	0.00432	CbGpPWpGaD
Dexamethasone—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00412	0.00412	CbGpPWpGaD
Dexamethasone—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.00411	0.00411	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00407	0.00407	CbGpPWpGaD
Dexamethasone—CYP1B1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00407	0.00407	CbGpPWpGaD
Dexamethasone—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00404	0.00404	CbGpPWpGaD
Dexamethasone—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00403	0.00403	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—POLR3A—conduct disorder	0.00399	0.00399	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00387	0.00387	CbGpPWpGaD
Dexamethasone—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00381	0.00381	CbGpPWpGaD
Dexamethasone—ANXA1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00378	0.00378	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR ligand binding—HTR2A—conduct disorder	0.00366	0.00366	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—CGA—conduct disorder	0.00356	0.00356	CbGpPWpGaD
Dexamethasone—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00349	0.00349	CbGpPWpGaD
Dexamethasone—CYP19A1—Biological oxidations—COMT—conduct disorder	0.00344	0.00344	CbGpPWpGaD
Dexamethasone—CYP19A1—Biological oxidations—MAOA—conduct disorder	0.00341	0.00341	CbGpPWpGaD
Dexamethasone—CYP19A1—Metapathway biotransformation—COMT—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Dexamethasone—NR3C1—Regulation of Androgen receptor activity—EP300—conduct disorder	0.00333	0.00333	CbGpPWpGaD
Dexamethasone—CYP1B1—Biological oxidations—COMT—conduct disorder	0.00331	0.00331	CbGpPWpGaD
Dexamethasone—CYP1B1—Biological oxidations—MAOA—conduct disorder	0.00328	0.00328	CbGpPWpGaD
Dexamethasone—CYP1B1—Metapathway biotransformation—COMT—conduct disorder	0.00326	0.00326	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00325	0.00325	CbGpPWpGaD
Dexamethasone—NR3C1—Circadian Clock—EP300—conduct disorder	0.00323	0.00323	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00323	0.00323	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—DRD4—conduct disorder	0.00317	0.00317	CbGpPWpGaD
Dexamethasone—CYP4A11—PPARA activates gene expression—EP300—conduct disorder	0.00315	0.00315	CbGpPWpGaD
Dexamethasone—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00312	0.00312	CbGpPWpGaD
Dexamethasone—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00308	0.00308	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CGA—conduct disorder	0.00304	0.00304	CbGpPWpGaD
Dexamethasone—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00298	0.00298	CbGpPWpGaD
Dexamethasone—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00296	0.00296	CbGpPWpGaD
Dexamethasone—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00294	0.00294	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00292	0.00292	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00288	0.00288	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—DRD4—conduct disorder	0.00288	0.00288	CbGpPWpGaD
Dexamethasone—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00287	0.00287	CbGpPWpGaD
Dexamethasone—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00284	0.00284	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00283	0.00283	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00281	0.00281	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—CGA—conduct disorder	0.00281	0.00281	CbGpPWpGaD
Dexamethasone—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00278	0.00278	CbGpPWpGaD
Dexamethasone—NOS2—Circadian rythm related genes—EP300—conduct disorder	0.00274	0.00274	CbGpPWpGaD
Dexamethasone—CYP2A6—Biological oxidations—COMT—conduct disorder	0.00273	0.00273	CbGpPWpGaD
Dexamethasone—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.00272	0.00272	CbGpPWpGaD
Dexamethasone—NR3C1—AP-1 transcription factor network—EP300—conduct disorder	0.00267	0.00267	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00265	0.00265	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00263	0.00263	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00251	0.00251	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00251	0.00251	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—WASF1—conduct disorder	0.00243	0.00243	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—POLR3A—conduct disorder	0.00243	0.00243	CbGpPWpGaD
Dexamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—conduct disorder	0.00237	0.00237	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—conduct disorder	0.00235	0.00235	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00228	0.00228	CbGpPWpGaD
Dexamethasone—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00221	0.00221	CbGpPWpGaD
Dexamethasone—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00219	0.00219	CbGpPWpGaD
Dexamethasone—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00218	0.00218	CbGpPWpGaD
Dexamethasone—CYP2E1—Biological oxidations—COMT—conduct disorder	0.00216	0.00216	CbGpPWpGaD
Dexamethasone—CYP3A5—Biological oxidations—COMT—conduct disorder	0.00216	0.00216	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—CGA—conduct disorder	0.00215	0.00215	CbGpPWpGaD
Dexamethasone—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.00215	0.00215	CbGpPWpGaD
Dexamethasone—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00214	0.00214	CbGpPWpGaD
Dexamethasone—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.00213	0.00213	CbGpPWpGaD
Dexamethasone—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.00213	0.00213	CbGpPWpGaD
Dexamethasone—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00212	0.00212	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—HTR2A—conduct disorder	0.00207	0.00207	CbGpPWpGaD
Dexamethasone—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00204	0.00204	CbGpPWpGaD
Dexamethasone—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00202	0.00202	CbGpPWpGaD
Dexamethasone—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00201	0.00201	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—CGA—conduct disorder	0.00196	0.00196	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00195	0.00195	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—CGA—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—HTR2A—conduct disorder	0.00188	0.00188	CbGpPWpGaD
Dexamethasone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00187	0.00187	CbGpPWpGaD
Dexamethasone—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00187	0.00187	CbGpPWpGaD
Dexamethasone—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00185	0.00185	CbGpPWpGaD
Dexamethasone—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00184	0.00184	CbGpPWpGaD
Dexamethasone—PTGS2—C-MYB transcription factor network—EP300—conduct disorder	0.00175	0.00175	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CGA—conduct disorder	0.00172	0.00172	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—DRD4—conduct disorder	0.0017	0.0017	CbGpPWpGaD
Dexamethasone—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00167	0.00167	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CGA—conduct disorder	0.00166	0.00166	CbGpPWpGaD
Dexamethasone—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00166	0.00166	CbGpPWpGaD
Dexamethasone—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.00163	0.00163	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—COMT—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—MAOA—conduct disorder	0.0016	0.0016	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00159	0.00159	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00155	0.00155	CbGpPWpGaD
Dexamethasone—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00153	0.00153	CbGpPWpGaD
Dexamethasone—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00152	0.00152	CbGpPWpGaD
Dexamethasone—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00152	0.00152	CbGpPWpGaD
Dexamethasone—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00151	0.00151	CbGpPWpGaD
Dexamethasone—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00151	0.00151	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Dexamethasone—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CGA—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00142	0.00142	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—POLR3A—conduct disorder	0.00141	0.00141	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.0014	0.0014	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—WASF1—conduct disorder	0.00133	0.00133	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—EP300—conduct disorder	0.00131	0.00131	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CGA—conduct disorder	0.0013	0.0013	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00129	0.00129	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—COMT—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—MAOA—conduct disorder	0.00126	0.00126	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CGA—conduct disorder	0.00125	0.00125	CbGpPWpGaD
Dexamethasone—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00125	0.00125	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Dexamethasone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00122	0.00122	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CGA—conduct disorder	0.00114	0.00114	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CGA—conduct disorder	0.00113	0.00113	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—HTR2A—conduct disorder	0.00111	0.00111	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CGA—conduct disorder	0.00104	0.00104	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—COMT—conduct disorder	0.001	0.001	CbGpPWpGaD
Dexamethasone—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000995	0.000995	CbGpPWpGaD
Dexamethasone—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000989	0.000989	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—COMT—conduct disorder	0.00097	0.00097	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—MAOA—conduct disorder	0.000963	0.000963	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000934	0.000934	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—DRD4—conduct disorder	0.00093	0.00093	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000905	0.000905	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—COMT—conduct disorder	0.000887	0.000887	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—MAOA—conduct disorder	0.000881	0.000881	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—COMT—conduct disorder	0.000878	0.000878	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—MAOA—conduct disorder	0.000872	0.000872	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CGA—conduct disorder	0.00087	0.00087	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000854	0.000854	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000845	0.000845	CbGpPWpGaD
Dexamethasone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.000842	0.000842	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CGA—conduct disorder	0.000836	0.000836	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CGA—conduct disorder	0.000819	0.000819	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CGA—conduct disorder	0.000817	0.000817	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—COMT—conduct disorder	0.000779	0.000779	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—MAOA—conduct disorder	0.000773	0.000773	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CGA—conduct disorder	0.000772	0.000772	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00075	0.00075	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CGA—conduct disorder	0.000708	0.000708	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—EP300—conduct disorder	0.00069	0.00069	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—COMT—conduct disorder	0.00065	0.00065	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—MAOA—conduct disorder	0.000645	0.000645	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000642	0.000642	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EP300—conduct disorder	0.000633	0.000633	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CGA—conduct disorder	0.000632	0.000632	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000626	0.000626	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CGA—conduct disorder	0.000616	0.000616	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HTR2A—conduct disorder	0.000607	0.000607	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EP300—conduct disorder	0.000588	0.000588	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—COMT—conduct disorder	0.000588	0.000588	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—MAOA—conduct disorder	0.000583	0.000583	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CGA—conduct disorder	0.000581	0.000581	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CGA—conduct disorder	0.000576	0.000576	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—COMT—conduct disorder	0.000566	0.000566	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000566	0.000566	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—MAOA—conduct disorder	0.000562	0.000562	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000545	0.000545	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—EP300—conduct disorder	0.000543	0.000543	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—COMT—conduct disorder	0.000515	0.000515	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—MAOA—conduct disorder	0.000511	0.000511	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—COMT—conduct disorder	0.00051	0.00051	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—MAOA—conduct disorder	0.000507	0.000507	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—COMT—conduct disorder	0.000468	0.000468	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—MAOA—conduct disorder	0.000464	0.000464	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—EP300—conduct disorder	0.000416	0.000416	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—COMT—conduct disorder	0.000393	0.000393	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—MAOA—conduct disorder	0.00039	0.00039	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—EP300—conduct disorder	0.00038	0.00038	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CGA—conduct disorder	0.00038	0.00038	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000378	0.000378	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—COMT—conduct disorder	0.000377	0.000377	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—EP300—conduct disorder	0.000377	0.000377	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—MAOA—conduct disorder	0.000375	0.000375	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—COMT—conduct disorder	0.00037	0.00037	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—COMT—conduct disorder	0.000369	0.000369	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—MAOA—conduct disorder	0.000367	0.000367	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—MAOA—conduct disorder	0.000366	0.000366	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—COMT—conduct disorder	0.000348	0.000348	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—MAOA—conduct disorder	0.000346	0.000346	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000335	0.000335	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—EP300—conduct disorder	0.000334	0.000334	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EP300—conduct disorder	0.000321	0.000321	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—COMT—conduct disorder	0.000319	0.000319	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MAOA—conduct disorder	0.000317	0.000317	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000308	0.000308	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—COMT—conduct disorder	0.000285	0.000285	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MAOA—conduct disorder	0.000283	0.000283	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—EP300—conduct disorder	0.000279	0.000279	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—COMT—conduct disorder	0.000278	0.000278	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MAOA—conduct disorder	0.000276	0.000276	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000275	0.000275	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—COMT—conduct disorder	0.000262	0.000262	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MAOA—conduct disorder	0.00026	0.00026	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—COMT—conduct disorder	0.00026	0.00026	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MAOA—conduct disorder	0.000258	0.000258	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—EP300—conduct disorder	0.000252	0.000252	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00025	0.00025	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—EP300—conduct disorder	0.000243	0.000243	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—EP300—conduct disorder	0.000221	0.000221	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—EP300—conduct disorder	0.000219	0.000219	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EP300—conduct disorder	0.000201	0.000201	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—EP300—conduct disorder	0.000201	0.000201	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—COMT—conduct disorder	0.000171	0.000171	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MAOA—conduct disorder	0.00017	0.00017	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—EP300—conduct disorder	0.000168	0.000168	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—EP300—conduct disorder	0.000162	0.000162	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—EP300—conduct disorder	0.000158	0.000158	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—EP300—conduct disorder	0.000158	0.000158	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—EP300—conduct disorder	0.000149	0.000149	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—EP300—conduct disorder	0.000137	0.000137	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—EP300—conduct disorder	0.000122	0.000122	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—EP300—conduct disorder	0.000119	0.000119	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—EP300—conduct disorder	0.000112	0.000112	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—EP300—conduct disorder	0.000111	0.000111	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—EP300—conduct disorder	7.35e-05	7.35e-05	CbGpPWpGaD
